{
  "actions": [
    {
      "acted_at": "2021-05-20",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2021-05-20",
      "action_code": "",
      "committees": [
        "SSBK"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s1745-117",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Banking, Housing, and Urban Affairs",
      "committee_id": "SSBK"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "C001056",
      "district": null,
      "name": "Cornyn, John",
      "original_cosponsor": true,
      "sponsored_at": "2021-05-20",
      "state": "TX",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2021-05-20",
  "number": "1745",
  "official_title": "A bill to strengthen the requirements for reviews by the Committee on Foreign Investment in the United States of covered transactions involving genetic information, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "GENE Act",
  "sponsor": {
    "bioguide_id": "R000595",
    "district": null,
    "name": "Rubio, Marco",
    "state": "FL",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2021-05-20",
  "subjects": [
    "Congressional oversight",
    "Corporate finance and management",
    "Foreign and international corporations",
    "Foreign trade and international finance",
    "Genetics",
    "Government studies and investigations",
    "Health information and medical records",
    "Medical tests and diagnostic methods",
    "U.S. and foreign investments"
  ],
  "subjects_top_term": "Foreign trade and international finance",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2021-05-20",
    "date": "2021-12-26T15:03:47Z",
    "text": "Genomics Expenditures and National security Enhancement Act of 2021 or the GENE Act\n\nThis bill establishes oversight requirements for certain foreign investments in a U.S. business that maintains or collects information about the genetic tests of U.S. citizens (including information relating to genomic sequencing).\n\nSpecifically, the Committee on Foreign Investment in the United States (CFIUS) must require the parties to specified transactions (e.g., mergers, acquisitions, or takeovers by or with any foreign person that could result in foreign control of any U.S. business) to submit a mandatory declaration containing basic information regarding the transaction.\n\nFurther, CFIUS must consult with the Department of Health and Human Services in any review or investigation of a covered transaction that involves this type of investment by a foreign person in a U.S. business.\n\nThe bill also expands the congressional committees to which CFIUS must give annual testimony concerning foreign investment in the United States to include (1) the Committee on Foreign Relations of the Senate, (2) the Select Committee on Intelligence of the Senate, (3) the Committee on Foreign Affairs of the House of Representatives, and (4) the Permanent Select Committee on Intelligence of the House of Representatives. Currently, such testimony is only given to the Committee on Financial Services of the House of Representatives and the Committee on Banking, Housing, and Urban Affairs of the Senate."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "GENE Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to strengthen the requirements for reviews by the Committee on Foreign Investment in the United States of covered transactions involving genetic information, and for other purposes.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "GENE Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Genomics Expenditures and National security Enhancement Act of 2021",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-11T13:50:07Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/s/BILLSTATUS-117s1745.xml"
}